Alliance Global Partners Starts Adial Pharmaceuticals Inc (ADIL) at Buy
Tweet
Share
E-mailGet Alerts ADIL Hot Sheet
Price: $6.22 +5.42%
Rating Summary:
7 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 6 | New: 26
Rating Summary:
7 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 6 | New: 26
Join SI Premium – FREE
Alliance Global Partners analyst James Molloy initiates coverage on Adial Pharmaceuticals Inc (NASDAQ: ADIL) with a Buy rating and a price target of $11.00.
For an analyst ratings summary and ratings history on Adial Pharmaceuticals Inc click here. For more ratings news on Adial Pharmaceuticals Inc click here.
Shares of Adial Pharmaceuticals Inc closed at $3.34 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Emkay Global Starts Urban Company (URBANCO:IN) at Buy (1)
- Wolfe Research sees CNH stock flat 2027 outlook on commodity prices
- Jefferies sees metals breakout on currency concerns
Create E-mail Alert Related Categories
New CoverageRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
